Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Touchstone International Medical Science Co., Ltd. specializes in the development and manufacturing of advanced medical instruments and supplies, primarily targeting the Chinese healthcare market. The company differentiates itself through its proprietary technology and a strong focus on R&D, which has led to a robust pipeline of innovative products.
Touchstone generates revenue primarily through the sale of high-margin medical instruments and consumables. Its competitive advantages include a strong R&D capability that allows for rapid innovation and adaptation to market needs, as well as established relationships with hospitals and clinics across China.
Regulatory approvals for new medical devices
Changes in healthcare spending in China
Partnerships with hospitals for product adoption
Advancements in proprietary technology
Regulatory changes affecting medical device approvals
Technological disruption from new entrants in the medical supply market
Increased competition from both domestic and international medical supply companies
Potential for price wars in the medical instruments sector
Low liquidity risk due to a strong current ratio of 3.54
Minimal debt exposure with a debt/equity ratio of 0.13
moderate - The company's performance is somewhat linked to GDP growth and healthcare spending, which can fluctuate with economic cycles.
Minimal - The company has low debt levels, so rising interest rates do not significantly impact financing costs or demand.
minimal - Touchstone's operations are not heavily reliant on credit markets.
growth - Investors are likely attracted to the company's strong revenue growth and innovative product pipeline.
high - The stock has shown significant volatility, as evidenced by a 48.5% decline over the past six months.
